Form D · Hedge Fund

Farallon Healthcare Partners, L.P.

San Francisco, CA · CIK 0001871851

Offering snapshot reported Jul 17, 2026 · SEC filing

Reported sold: $651M
Investors reported: 59
Minimum accepted: $0
First sale: Jul 1, 2021

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$510,510,326 → $650,626,667
Reported investors51 → 59

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 17, 2026	Amendment	$650,626,667	$140,116,341vs Jul 17, 2025	59	SEC filing
Jul 17, 2025	Amendment	$510,510,326	$78,550,000vs Jul 18, 2024	51	SEC filing
Jul 18, 2024	Amendment	$431,960,326	$11,250,000vs Jul 17, 2023	47	SEC filing
Jul 17, 2023	Amendment	$420,710,326	$154,000,000vs Jul 15, 2022	47	SEC filing
Jul 15, 2022	Amendment	$266,710,326	$41,834,968vs Jul 15, 2021	44	SEC filing
Jul 15, 2021	Initial	$224,875,358	No comparison	Not reported	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-406430

Amount sold reflects only amount sold by Issuer. Issuer participates in the same investment strategy as Farallon Healthcare Partners International, Ltd ("Offshore Fund"). Total amount sold by the Issuer and the Offshore Fund is approx. $1.6 billion.

Source: Form D, filed Jul 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

FARALLON HEALTHCARE PARTNERS, L.P.

Investment adviser: FARALLON CAPITAL MANAGEMENT, L.L.C.

Gross asset value: Not reported
Beneficial owners: Not reported
ADV minimum commitment: Not reported

Reported in Form ADV on Sep 23, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

No provider names available in this fund's imported disclosure.

Provider details

Annual audit: Not reported
Prime brokers: Not reported
Custodians: Not reported
Administrator other than the adviser: Not reported
External marketing: Not reported

Filing source

Form ADV 2116932 · Sep 23, 2026 · Schedule D 7.B.(1), fund 805-8833663731

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Richard P. Bollini	Executive
Colby Trexler Clark	Executive
Joshua Dapice	Executive
Philip D. Dreyfuss	Executive
Hannah Dunn	Executive
N/A Farallon Capital Management, L.L.C.	Executive
N/A Farallon Healthcare Partners (Gp), L.L.C	Executive
Michael B Fisch	Executive
Richard B. Fried	Executive
Varun Gehani	Executive
Nicolas Giauque	Executive
Cameron Hillyer	Executive
Avner Husen	Executive
David T. Kim	Executive
Michael G. Linn	Executive
Patrick Luo	Executive
Rajiv A. Patel	Executive
David A. Posner	Executive
Dr. Thomas G. Roberts, Jr.	Executive
Edric Saito	Executive
William S. Seybold	Executive
Daniel S. Short	Executive
Andrew J.M. Spokes	Executive
Matthew Trentini	Executive
John R. Warren	Executive
Mark C. Wehrly	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

Farallon Healthcare Partners, L.P. One Maritime Plaza, Suite 2100
San Francisco, CA, 94111